NCT02693522View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Growth Hormone Deficiency
Interventions
DRUG

somatropin

Subcutaneous injection

DRUG

Eutropin

Subcutaneous injection

Trial Locations (1)

Unknown

Kyunghee University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY